Bjerager, Jakob
Hajari, Javad
Klefter, Oliver Niels
Subhi, Yousif
Schneider, Miklos
Article History
Received: 4 September 2023
Accepted: 29 October 2023
First Online: 8 February 2024
Declarations
:
: Author M.S. has received investigator fees from Allergan, Bayer, Novartis, and Roche and has served as an advisory board member for Novartis and Roche and acted as consultant for AbbVie, not related to this work. Author Y.S. declares to have received speakers fee from Bayer and Roche, not related to this work. Other authors declare that no potential conflicts of interests exist in relation to this work.